Breaking News
Investing Pro 0
🚨 NDVA surged 43%. This AI Chipmaker Could Be Next See Analysis
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
71.280 0.000    0.00%
01/06 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 64.960 / 66.780
  • Day's Range: 71.280 - 72.360
Type:  Equity
Market:  Austria
ISIN:  US3755581036 
Gilead 71.280 0.000 0.00%

GILD Technical Analysis

 
Gilead share technical analysis data, signals range from strong buy, buy, neutral, sell to strong Sell. Assess a detailed technical analysis based on the buy/sell signals of moving averages (simple and exponential for a wide range of periods) and buy, sell, overbought, oversold or neutral signals of common chart indicators (including RSI, MACD and CCI). View the GILD stock analysis data across your chosen time frame.
Summary:Strong Sell
Moving Averages:Strong SellBuy (0)Sell (12)
Technical Indicators:Strong SellBuy (0)Sell (10)

Pivot PointsJun 02, 2023 16:20 GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 70.586 70.853 71.386 71.653 72.186 72.453 72.986
Fibonacci 70.853 71.159 71.347 71.653 71.959 72.147 72.453
Camarilla 71.700 71.773 71.847 71.653 71.993 72.067 72.140
Woodie's 70.720 70.920 71.520 71.720 72.320 72.520 73.120
DeMark's - - 71.520 71.720 72.320 - -

Technical IndicatorsJun 02, 2023 16:20 GMT

Name Value Action
RSI(14) 42.623 Sell
STOCH(9,6) 24.123 Sell
STOCHRSI(14) 30.511 Sell
MACD(12,26) -0.638 Sell
ADX(14) 51.828 Sell
Williams %R -92.983 Oversold
CCI(14) -81.2803 Sell
ATR(14) 0.9129 Less Volatility
Highs/Lows(14) -0.7071 Sell
Ultimate Oscillator 35.320 Sell
ROC -1.137 Sell
Bull/Bear Power(13) -0.3880 Sell

Buy: 0

Sell: 10

Neutral: 0


Summary:Strong Sell

Moving AveragesJun 02, 2023 16:20 GMT

Period Simple Exponential
MA5 71.724
Sell
71.705
Sell
MA10 72.230
Sell
71.844
Sell
MA20 71.969
Sell
72.501
Sell
MA50 73.918
Sell
73.743
Sell
MA100 75.640
Sell
74.370
Sell
MA200 74.686
Sell
73.023
Sell

Buy: 0

Sell: 12


Summary:Strong Sell

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email